Research programme: AAV gene therapies - Dyno Therapeutics/Roche
Latest Information Update: 14 Nov 2024
Price :
$50 *
At a glance
- Originator Dyno Therapeutics; Roche
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Neurological disorders